Neuroprotection in Traumatic Brain Injury: Mesenchymal Stromal Cells can Potentially Overcome Some Limitations of Previous Clinical Trials
Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. In the last 30 years several neuroprotective agents, attenuating the downstream molecular and cellular damaging events triggered by TBI, have been extensively studied. Even though many drugs have shown promising resul...
Main Authors: | Marco Carbonara, Francesca Fossi, Tommaso Zoerle, Fabrizio Ortolano, Federico Moro, Francesca Pischiutta, Elisa R. Zanier, Nino Stocchetti |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-10-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2018.00885/full |
Similar Items
-
Rethinking Neuroprotection in Severe Traumatic Brain Injury: Toward Bedside Neuroprotection
by: Tommaso Zoerle, et al.
Published: (2017-07-01) -
Cerebral metabolism is not affected by moderate hyperventilation in patients with traumatic brain injury
by: Giovanna Brandi, et al.
Published: (2019-02-01) -
Virtual Reality for Traumatic Brain Injury
by: Elisa R. Zanier, et al.
Published: (2018-05-01) -
Neuroprotective Effects of Bone Marrow Stromal Cell Transplantation in Combination With Treadmill Exercise Following Traumatic Brain Injury
by: Mal Soon Shin, et al.
Published: (2016-05-01) -
Brain Metastasis from Gastrointestinal Stromal Tumor: A Case Report and Review of the Literature
by: Hideaki Naoe, et al.
Published: (2011-10-01)